Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson's disease-Reference-Cited by-同舟云学术

Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson's disease

Published:2009-06 Issue:7 Volume:54 Page:418-425
ISSN:0197-0186
Container-title:Neurochemistry International
language:en
Short-container-title:Neurochemistry International

Author:

Pan Jing,Xiao Qin,Sheng Cheng-Yu,Hong Zhen,Yang Hong-Qi,Wang Gang,Ding Jian-Qing,Chen Sheng-Di

Publisher

Elsevier BV

Subject

Cell Biology,Cellular and Molecular Neuroscience

Reference40 articles.

1. Microarray analysis of oxidative stress regulated genes in mesencephalic dopaminergic neuronal cells: relevance to oxidative damage in Parkinson's disease;Anantharam;Neurochem. Int.,2007

2. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia;Borsello;Nat. Med.,2003

3. Specific pathophysiological functions of JNK isoforms in the brain;Brecht;Eur. J. Neurosci.,2005

4. Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction;Brint;J. Biol. Chem.,2002

5. Role of the JNK pathway in NMDA-mediated excitotoxicity of cortical neurons;Centeno;Cell. Death. Differ.,2007

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dipeptide mimetic of BDNF ameliorates motor dysfunction and striatal apoptosis in 6-OHDA-induced Parkinson’s rat model: Considering Akt and MAPKs signaling;Behavioural Brain Research;2023-08

2. The Effects of Serping1 siRNA in α-Synuclein Regulation in MPTP-Induced Parkinson’s Disease;Biomedicines;2023-07-10

3. Emerging Roles of Signal Transduction Pathways in Neurodegenerative Diseases. Hunting New Possible Therapeutic Molecular Targets;OBM Geriatrics;2023-05-05

4. Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson's Disease;J MED CHEM;2023

5. Discovery of Novel Indazole Chemotypes as Isoform-Selective JNK3 Inhibitors for the Treatment of Parkinson’s Disease;Journal of Medicinal Chemistry;2023-01-17